Fig. 1 · Structure
Documents & Downloads
LY288513
CCK-B Receptor Antagonist
LY288513 is a selective non-peptide antagonist of the cholecystokinin B (CCK-B) receptor, exhibiting an IC50 value of 16 nM. It has been demonstrated to produce anxiolytic-like effects in murine models, making it a valuable tool for research in anxiety disorders and related neurobiological studies. Its specificity for the CCK-B receptor allows for targeted investigation into the mechanisms underlying anxiety and stress responses.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 147523-65-7 |
| Applications | CCK-B Receptor Antagonist |
| Formula | C22H18BrN3O2 |
| Molecular Weight | 436.30 |
| SMILES | O=C(N1NC([C@@H](C2=CC=CC=C2)[C@@H]1C3=CC=CC=C3)=O)NC4=CC=C(Br)C=C4 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.